These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies. Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774 [TBL] [Abstract][Full Text] [Related]
4. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents. Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006 [TBL] [Abstract][Full Text] [Related]
5. DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway. Zhou D; Zhou W; Song JK; Feng ZY; Yang RY; Wu S; Wang L; Liu AL; Du GH Acta Pharmacol Sin; 2016 Nov; 37(11):1401-1412. PubMed ID: 27498773 [TBL] [Abstract][Full Text] [Related]
6. Synthetic β-hydroxy ketone derivative inhibits cholinesterases, rescues oxidative stress and ameliorates cognitive deficits in 5XFAD mice model of AD. Ahmad SI; Ali G; Muhammad T; Ullah R; Umar MN; Hashmi AN Mol Biol Rep; 2020 Dec; 47(12):9553-9566. PubMed ID: 33211296 [TBL] [Abstract][Full Text] [Related]
7. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components. Farías GG; Godoy JA; Vázquez MC; Adani R; Meshulam H; Avila J; Amitai G; Inestrosa NC Neurobiol Dis; 2005 Feb; 18(1):176-83. PubMed ID: 15649708 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease. Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer's Disease. Singh G; Kumar S; Panda SR; Kumar P; Rai S; Verma H; Singh YP; Kumar S; Srikrishna S; Naidu VGM; Modi G ACS Chem Neurosci; 2024 Aug; 15(15):2756-2778. PubMed ID: 39076038 [TBL] [Abstract][Full Text] [Related]
10. The selective butyrylcholinesterase inhibitor UW-MD-95 shows symptomatic and neuroprotective effects in a pharmacological mouse model of Alzheimer's disease. Carles A; Hoffmann M; Scheiner M; Crouzier L; Bertrand-Gaday C; Chatonnet A; Decker M; Maurice T CNS Neurosci Ther; 2024 Jun; 30(6):e14814. PubMed ID: 38887858 [TBL] [Abstract][Full Text] [Related]
11. CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease. Jiao W; Wang Y; Kong L; Ou-Yang T; Meng Q; Fu Q; Hu Z Biochem Biophys Res Commun; 2018 Jul; 501(4):1016-1022. PubMed ID: 29777699 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo. Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744 [TBL] [Abstract][Full Text] [Related]
13. Cyanidin improves spatial memory and cognition in bisphenol A-induced rat model of Alzheimer's-like neuropathology by restoring canonical Wnt signaling. Suresh S; Vellapandian C Toxicol Appl Pharmacol; 2024 Jun; 487():116953. PubMed ID: 38705400 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease. Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430 [TBL] [Abstract][Full Text] [Related]
15. Imino-2H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study. Attarroshan M; Firuzi O; Iraji A; Sharifi S; Tavakkoli M; Vesal M; Khoshneviszadeh M; Pirhadi S; Edraki N Chem Biodivers; 2022 Jan; 19(1):e202100599. PubMed ID: 34786830 [TBL] [Abstract][Full Text] [Related]
16. Icariin ameliorates glycolytic dysfunction in Alzheimer's disease models by activating the Wnt/β-catenin signaling pathway. Liu J; Wei AH; Liu TT; Ji XH; Zhang Y; Yan F; Chen MX; Hu JB; Zhou SY; Shi JS; Jin H; Jin F FEBS J; 2024 May; 291(10):2221-2241. PubMed ID: 38400523 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831 [TBL] [Abstract][Full Text] [Related]
18. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002 [TBL] [Abstract][Full Text] [Related]
19. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease. Jiang X; Zhang Z; Zuo J; Wu C; Zha L; Xu Y; Wang S; Shi J; Liu XH; Zhang J; Tang W Eur J Med Chem; 2021 Nov; 223():113735. PubMed ID: 34371367 [TBL] [Abstract][Full Text] [Related]
20. TL-2 attenuates β-amyloid induced neuronal apoptosis through the AKT/GSK-3β/β-catenin pathway. Zhu X; Wang S; Yu L; Yang H; Tan R; Yin K; Jin J; Zhao H; Guan D; Xu Y Int J Neuropsychopharmacol; 2014 Sep; 17(9):1511-9. PubMed ID: 24641999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]